Enacts the manufacturer disclosure and transparency act

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 22 Sponsors

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Chamber: Senate
Introduced: Jan 8, 2025
Last action: May 12, 2026 — REFERRED TO CONSUMER AFFAIRS AND PROTECTION
Session: 2025-2026
Momentum: 66 · High

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +4 66/100 from the pace of recorded action
Time since last action -22 156 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.